Related Experiment Video

Updated: May 27, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Update on the clinical management of atrial fibrillation: guidelines and beyond

Anne B Curtis1

  • 1University at Buffalo, Buffalo, NY 14215, USA. abcurtis@buffalo.edu

Postgraduate Medicine
|November 23, 2011
PubMed

Insights

Managing atrial fibrillation (AF) is complex due to treatment challenges and poor patient compliance. This review updates physicians on guideline-based AF management and new FDA-approved therapies.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Pharmacology

Background:

  • Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia, with increasing prevalence due to population aging.
  • Managing AF involves rate/rhythm control and thromboprophylaxis, complicated by side effects, comorbidities, and anticoagulation adherence issues.
  • Poor adherence to anticoagulation significantly increases mortality, stroke risk, and diminishes quality of life and exercise capacity.

Purpose of the Study:

  • To provide physicians with an updated guide on managing atrial fibrillation (AF).
  • To focus on key therapeutic components from recent (2011) ACC/AHA/HRS guidelines for AF management.
  • To highlight new US Food and Drug Administration-approved treatments for AF.

Main Methods:

  • Review of current clinical practice guidelines for atrial fibrillation (AF) management.
  • Analysis of recent updates from ACC Foundation, AHA, and Heart Rhythm Society (2011).
  • Inclusion of information on new US FDA-approved AF treatments.

Main Results:

  • Guidelines provide a framework for AF management, integrating rate/rhythm control and thromboprophylaxis.
  • Adherence to anticoagulation is critical for reducing adverse outcomes like stroke and mortality.
  • New pharmacologic options and treatment strategies have emerged since previous guidelines.

Conclusions:

  • Effective AF management requires a comprehensive approach addressing therapy adherence and guideline-based strategies.
  • Physicians need to stay informed about updated guidelines and novel treatments to optimize patient care.
  • Improving patient compliance with anticoagulation is paramount to mitigate risks associated with atrial fibrillation.

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Robotic Ablation of Atrial Fibrillation11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...